Ken Houghton notes that the first thing anyone learns from Pietra Rivoli’s The Travels of a T-Shirt in the Global Economy: An Economist Examines the Markets, Power, and Politics of World Trade is how pernicious the U.S. subsidy of its cotton industry is.* Now the WTO has discovered the obvious:
American goods will face [$294.7] million in annual sanctions as a result of the United States’ failure to eliminate illegal subsidies to domestic cotton growers, the World Trade Organization ruled Monday.
The NYT attempts to spin this as a loss for the complainants:
The result was disappointing for Brazil, which has won a series of rulings against the United States over the last seven years. The Latin American country had sought to target American goods and drug patents for $2.5 billion worth of economic retaliation.
But gets to the order-of-magnitude-other-way-part a few paragraphs later:
Washington had argued that the award should not exceed $30 million.
So no one is happy, but it’s a start:
“The subsidies paid by the United States to its 25,000 cotton farmers exceed the entire gross national income of virtually every cotton-exporting country in West and Central Africa,” Mr. McGivern said. “Despite several rounds of litigation and ministerial-level negotiations, this issue remains unresolved.”
The cotton case was the first agricultural case started by a developing country in the group’s history.
The issue of generic drugs and trade is dealt with in this Health Affairs piece (of which maybe more later).
Meanwhile, those interested in a certain absurd claim previous dealt with by Susan of Texas (see here and here, for instance) and others, check out this press release from Health Affairs from last week. Good thing those countries don’t have a system that supports pharmaceutical innovation and investment better than the U.S. one.